PTN Logo

Palatin Technologies, Inc. (PTN) 

AMEX
Market Cap
$18.18M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
304 of 774
Rank in Industry
178 of 432

Largest Insider Buys in Sector

PTN Stock Price History Chart

PTN Stock Performance

About Palatin Technologies, Inc.

Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a …

Insider Activity of Palatin Technologies, Inc.

Over the last 12 months, insiders at Palatin Technologies, Inc. have bought $12,703 and sold $44,766 worth of Palatin Technologies, Inc. stock.

On average, over the past 5 years, insiders at Palatin Technologies, Inc. have bought $52,732 and sold $23,447 worth of stock each year.

Highest buying activity among insiders over the last 12 months: DEVEER ROBERT K JR (director) — $12,703.

The last purchase of 6,000 shares for transaction amount of $12,703 was made by DEVEER ROBERT K JR (director) on 2024‑04‑11.

List of Insider Buy and Sell Transactions, Palatin Technologies, Inc.

2024-08-01SaleExecutive VP and CFO/COO
4,999
0.0253%
$1.66$8,274-24.26%
2024-04-11Purchasedirector
6,000
0.0394%
$2.12$12,703-16.75%
2024-03-06Saledirector
11,700
0.0789%
$2.00$23,434-9.68%
2023-12-06SaleExecutive VP and CFO/COO
4,998
0.0341%
$2.51$12,563-28.88%
2023-12-04Saledirector
200
0.0014%
$2.48$496-23.97%
2022-12-27PurchasePresident and CEO
10,000
0.093%
$2.23$22,297+4.28%
2022-12-27PurchaseExecutive VP and CFO/COO
10,000
0.0928%
$2.22$22,245+4.28%
2022-12-21Saledirector
200
0.002%
$2.97$594-16.67%
2021-07-01Purchasedirector
10,000
0.0041%
$0.61$6,100-30.65%
2021-07-01Purchasedirector
33,000
0.0139%
$0.62$20,460-30.65%
2021-06-30PurchasePresident and CEO
75,000
0.0319%
$0.62$46,394-29.51%
2021-06-30PurchaseExecutive VP and CFO/COO
75,000
0.0318%
$0.62$46,238-29.51%
2021-06-30Purchasedirector
20,000
0.0085%
$0.62$12,350-29.51%
2020-11-18Purchasedirector
54,000
0.0215%
$0.41$22,140+25.00%
2020-09-29Saledirector
54,000
0.0219%
$0.46$24,980+14.58%
2019-08-05Purchasedirector
800
0.0003%
$0.78$627-16.67%
2019-08-02PurchasePresident and CEO
20,000
0.0088%
$0.86$17,260-20.24%
2019-08-01PurchasePresident and CEO
30,000
0.0128%
$0.86$25,859-22.41%
2019-08-01PurchaseExecutive VP and CFO/COO
50,000
0.0214%
$0.86$43,250-22.41%
2019-08-01Purchasedirector
22,580
0.0096%
$0.86$19,419-22.41%

Insider Historical Profitability

<0.0001%
WILLS STEPHEN TExecutive VP and CFO/COO
235456
1.2045%
$0.93102<0.0001%
DUNTON ALAN Wdirector
45074
0.2306%
$0.93103+11.66%
DEVEER ROBERT K JRdirector
40845
0.2089%
$0.9352<0.0001%
Hull Joseph Stanleydirector
775966
3.9695%
$0.9350<0.0001%
Morris Arlenedirector
698666
3.5741%
$0.9320+0.62%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
The Vanguard Group$1.11M3.68594,491+8.36%+$85,775.09<0.0001
LINSCO PRIVATE LEDGER CORP$273,761.000.91146,3960%+$0<0.0001
BlackRock$223,499.000.74119,5180%+$0<0.0001
Geode Capital Management$220,991.000.73118,160+25.5%+$44,908.90<0.0001
Squarepoint Ops LLC$101,623.000.3454,344New+$101,623.00<0.0001
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.